Weiss Multi-Strategy Advisers’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
Weiss Multi-Strategy Advisers's RARE Position: Q2 2018 in Review
Weiss Multi-Strategy Advisers sold out of Ultragenyx Pharmaceutical (RARE) in Q2 2018, closing a stake of 5,000 shares — an estimated $255K sold.
Weiss Multi-Strategy Advisers first reported a position in RARE in Q1 2014 and held it in 13 quarters. The position peaked at $14.7M in Q2 2015. 158 funds tracked by Wall St. Rank hold RARE as of Q2 2018.
- Weiss Multi-Strategy Advisers reported no remaining Ultragenyx Pharmaceutical position as of Q2 2018 after selling out during the quarter.
- Weiss Multi-Strategy Advisers sold 5,000 Ultragenyx Pharmaceutical shares in Q2 2018, an estimated $255K.
- Weiss Multi-Strategy Advisers first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and held it in 13 quarters.
- Weiss Multi-Strategy Advisers's Ultragenyx Pharmaceutical position peaked at $14.7M in Q2 2015.
- 158 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2018.
Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2018, filed 14 Aug 2018.